Astal Laboratories Balance Sheet Health
Financial Health criteria checks 3/6
Astal Laboratories has a total shareholder equity of ₹233.4M and total debt of ₹3.1M, which brings its debt-to-equity ratio to 1.3%. Its total assets and total liabilities are ₹366.1M and ₹132.7M respectively.
Key information
1.3%
Debt to equity ratio
₹3.12m
Debt
| Interest coverage ratio | n/a |
| Cash | ₹60.77m |
| Equity | ₹233.40m |
| Total liabilities | ₹132.74m |
| Total assets | ₹366.13m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 512600's short term assets (₹307.2M) exceed its short term liabilities (₹130.1M).
Long Term Liabilities: 512600's short term assets (₹307.2M) exceed its long term liabilities (₹2.6M).
Debt to Equity History and Analysis
Debt Level: 512600 has more cash than its total debt.
Reducing Debt: 512600's debt to equity ratio has increased from 0% to 1.3% over the past 5 years.
Debt Coverage: 512600's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if 512600's interest payments on its debt are well covered by EBIT.